glutamine has been researched along with ketamine in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (15.15) | 18.2507 |
2000's | 8 (24.24) | 29.6817 |
2010's | 18 (54.55) | 24.3611 |
2020's | 2 (6.06) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Böhmer, G; Schauer, W; Schmid, K | 1 |
Besson, MJ; Gauchy, C; Lantin le Boulch, N; Truong-Ngoc, NA | 1 |
Berglund, L; Gebre-Medhin, M; Lindberg, BS | 1 |
Bousquet, P; Chapleau, D; Crambes, A; Feldman, J; Monassier, L; Roegel, JC | 1 |
Avgovstides-Savvopoulou, P; Guiba-Tziampiri, O; Karkavelas, G; Loizidis, T; Soubasi, V; Spandou, E | 1 |
Abi-Dargham, A; Abi-Saab, W; Belger, A; Cooper, TB; D'Souza, DC; Gueorguieva, R; Krystal, JH; Macdougall, L; Madonick, SH; Perry, EB | 1 |
Murck, H; Ploch, M; Schaffler, K; Seibel, K; Spitznagel, H | 1 |
Assis, MA; Fonteles, MM; Freitas, RL; Freitas, RM; Pereira, MB; Silva, RF; Takahashi, RN | 1 |
Guimarães, FS; Leite, JV; Moreira, FA | 1 |
Atack, JR; Boggs, JD; Bonaventure, P; Galici, R; Miller, KL | 1 |
Barton, D; Grothey, A; Kottschade, L; Loprinzi, C; Wolf, S | 1 |
Glazkova, EN; Pyatin, VF; Tatarnikov, VS | 1 |
Tyurin, NL | 1 |
Cowen, PJ; Mhuircheartaigh, RN; Taylor, MJ; Tiangga, ER | 1 |
Baumann, J; Drevets, WC; Ibrahim, LA; Luckenbaugh, DA; Machado-Vieira, R; Marenco, S; Salvadore, G; Shen, J; van der Veen, JW; Zarate, CA; Zhang, Y | 1 |
Behar, KL; Cho, W; Chowdhury, GM; Rothman, DL; Sanacora, G; Thomas, MA | 1 |
Owen, RT | 1 |
Auer, DP; Fone, KC; Napolitano, A; Porkess, V; Schubert, MI; Shah, K | 1 |
Fam, J; Furby, H; Howes, OD; Hughes, E; Morgan, C; Pepper, F; Stone, JM | 1 |
Chatterjee, M; Dwivedi, AK; Kumari, R; Palit, G; Singh, S; Verma, AK; Verma, R | 1 |
Flood, P; Hunter, L; Kegeles, LS; Levinson, A; Mao, X; Milak, MS; Moore, H; Ogden, RT; Rodriguez, CI; Shungu, DC; Simpson, HB; Vermes, D; Xie, S | 1 |
Cooper, TB; Kegeles, LS; Keilp, JG; Mann, JJ; Mao, X; Milak, MS; Mulhern, ST; Ogden, RT; Oquendo, MA; Parter, AL; Proper, CJ; Rodriguez, CI; Shungu, DC; Suckow, RF | 1 |
Banasr, M; Behar, KL; Bristow, L; Chowdhury, GM; Duman, RS; Ma, X; Pittman, B; Rothman, DL; Sanacora, G; Schaeffer, E; Thomas, M; Zhang, J | 1 |
Barton-McArdle, A; Bolding, MS; Frölich, MA; Kraguljac, NV; Lahti, AC; Nichols, N; Reid, MA; Tran, S; White, DM | 1 |
Colic, L; Demenescu, LR; Fejtova, A; Heinze, HJ; Li, M; Metzger, CD; Salvadore, G; Speck, O; Steiner, J; Walter, M | 1 |
Kantrowitz, JT; Mann, JJ; Mao, X; Milak, MS; Shungu, DC | 1 |
Carlson, M; Carter, CS; Choo, TH; Corlett, PR; Girgis, RR; Grinband, J; Javitt, DC; Kantrowitz, JT; Kegeles, LS; Krystal, JH; Lesh, TA; Lieberman, JA; Maddock, RJ; Mason, G; Potter, WZ; Qiu, M; Ragland, JD; Robinson, J; Rothman, DL; Tanase, C; Wall, MM | 1 |
An, L; Banerjee, D; Evans, JW; Lally, N; Li, N; Nugent, AC; Roiser, JP; Shen, J; Snider, SL; Zarate, CA | 1 |
Fariborzi, M; Higley, MJ; Lur, G | 1 |
Payani, S; Pradeepkiran, JA; Priya, BL; Venkataramaiah, C | 1 |
Gärtner, M; Grimm, S; Henning, A; Lehmann, M; Scheidegger, M; Weigand, A; Wunder, A; Wyss, PO | 1 |
3 review(s) available for glutamine and ketamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Topics: Acetylcarnitine; Acetylcysteine; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Calcium; Glutamine; Humans; Infusions, Intravenous; Ketamine; Magnesium; Naphthalenes; Nootropic Agents; Paclitaxel; Peripheral Nervous System Diseases; Pyridines; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; Glutamine; Humans; Ketamine; Memantine; Riluzole; Treatment Outcome | 2012 |
6 trial(s) available for glutamine and ketamine
Article | Year |
---|---|
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
Topics: Amphetamine; Cognition; Dopamine; Double-Blind Method; Drug Interactions; Glutamine; Humans; Ketamine; Placebos; Prefrontal Cortex; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate | 2005 |
Hypericum extract reverses S-ketamine-induced changes in auditory evoked potentials in humans - possible implications for the treatment of schizophrenia.
Topics: Adult; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Evoked Potentials, Auditory; Female; Glutamine; Humans; Hypericum; Ketamine; Male; Middle Aged; Neuropsychological Tests; Phytotherapy; Plant Extracts; Schizophrenia; Schizophrenic Psychology | 2006 |
In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
Topics: Adult; Cross-Over Studies; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Male; Obsessive-Compulsive Disorder; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Treatment Outcome | 2015 |
Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities.
Topics: Adult; Antidepressive Agents; Double-Blind Method; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Ketamine; Magnetic Resonance Spectroscopy; Male; Middle Aged; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors; Young Adult | 2017 |
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
Topics: Adult; Antipsychotic Agents; Biomarkers; Brain; Drug Development; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neuroimaging; Oxygen; Psychotic Disorders; Receptors, Glutamate; Schizophrenia; Young Adult | 2018 |
7T
Topics: Adult; Antidepressive Agents; Brain; Cross-Over Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Male; Proton Magnetic Resonance Spectroscopy | 2018 |
24 other study(ies) available for glutamine and ketamine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Evidence for an involvement of NMDA and non-NMDA receptors in synaptic excitation of phrenic motoneurons in the rabbit.
Topics: 2-Amino-5-phosphonovalerate; Animals; Glutamine; Ketamine; Microinjections; Motor Neurons; Phrenic Nerve; Quinoxalines; Rabbits; Receptors, N-Methyl-D-Aspartate; Respiration; Spinal Cord; Synapses | 1991 |
In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
Topics: Anesthesia; Animals; Bicuculline; Calcium; Corpus Striatum; gamma-Aminobutyric Acid; Globus Pallidus; Glutamine; Glycine; Kainic Acid; Ketamine; Male; Nerve Endings; Neurons; Neurons, Afferent; Potassium; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Substantia Nigra | 1991 |
Plasma-free amino acid concentrations during ketamine anesthesia in the rhesus monkey: a short methodological study.
Topics: Amino Acids; Anesthesia; Animals; Arginine; Aspartic Acid; Female; Glutamine; Ketamine; Macaca mulatta; Methionine | 1991 |
GABAergic and glutaminergic modulation of centrally evoked arrhythmias in rats.
Topics: Animals; Arrhythmias, Cardiac; Baclofen; Brain; Cardiovascular System; Electric Stimulation; GABA Agonists; gamma-Aminobutyric Acid; Glutamine; Injections, Intravenous; Injections, Intraventricular; Ketamine; Kynurenic Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System; Synaptic Transmission | 1996 |
Effect of ketamine on hypoxic-ischemic brain damage in newborn rats.
Topics: Adenosine Triphosphate; Amino Acids; Animals; Animals, Newborn; Body Weight; Brain; Brain Ischemia; Carotid Artery Diseases; Female; Functional Laterality; Glutamic Acid; Glutamine; Hypoxia, Brain; Ketamine; Male; Neurons; Neuroprotective Agents; Phosphocreatine; Rats; Rats, Wistar; Time Factors | 1999 |
Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats.
Topics: Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Phenobarbital; Pilocarpine; Rats; Rats, Wistar; Receptors, GABA; Receptors, Neurotransmitter; Seizures; Status Epilepticus; Vigabatrin | 2007 |
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Partial Agonism; Excitatory Amino Acid Antagonists; Glutamine; Haloperidol; Hyperkinesis; Ketamine; Locomotion; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Time Factors | 2008 |
Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Topics: Amphetamine; Animals; Antipsychotic Agents; Arousal; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutamine; Injections, Intraperitoneal; Injections, Subcutaneous; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenols; Psychotic Disorders; Receptors, Serotonin; Reflex, Startle; Sulfonamides; Synaptic Transmission | 2008 |
Role of NMDA- and non-NMDA subtypes of glutamate receptors in A5 neuronal structures in the regulation of respiration and circulation during thermal nociceptive stimulation in rats.
Topics: Animals; Blood Pressure; Body Temperature; Excitatory Amino Acid Antagonists; Glutamine; Hot Temperature; Ketamine; Phrenic Nerve; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Respiratory Center | 2008 |
Role of neuronal NMDA and non-NMDA glutamate receptors in medial vestibular nucleus in the regulation of respiratory rhythmogenesis in newborn rats in vitro.
Topics: Animals; Animals, Newborn; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutamine; Ketamine; Periodicity; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Respiration; Respiratory Center; Vestibular Nuclei | 2009 |
Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study.
Topics: Adult; Cerebral Cortex; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Protons; Young Adult | 2012 |
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
Topics: Adult; Cerebral Cortex; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurotransmitter Agents; Predictive Value of Tests; Psychiatric Status Rating Scales; Retrospective Studies | 2012 |
¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism.
Topics: Affect; Animals; Carbon Isotopes; Cognition; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hippocampus; Hydrogen; Ketamine; Magnetic Resonance Spectroscopy; Male; Neuroglia; Neurotransmitter Agents; Perception; Prefrontal Cortex; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 2012 |
In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.
Topics: Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Ketamine; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Social Isolation | 2014 |
Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.
Topics: Adult; Aspartic Acid; Brain; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Spectroscopy; Male; Psychotic Disorders; Substance-Related Disorders; Young Adult | 2014 |
Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems.
Topics: Animals; Antipsychotic Agents; Bacopa; Dopamine; Dose-Response Relationship, Drug; Glutamine; Ketamine; Male; Mice; Plant Extracts; Psychotic Disorders; Serotonin | 2015 |
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.
Topics: Adult; Amino Acids; Antidepressive Agents; Brain; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Imaging; Male; Middle Aged; Neurotransmitter Agents; Pilot Projects; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Tritium | 2016 |
Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.
Topics: Animals; Antidepressive Agents; Brain; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Ketamine; Magnetic Resonance Spectroscopy; Male; Phenols; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Scopolamine | 2017 |
Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.
Topics: Adult; Brain; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Healthy Volunteers; Hippocampus; Humans; Ketamine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurochemistry; Neuroimaging; Prefrontal Cortex; Rest | 2017 |
d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine.
Topics: Brain Chemistry; Cycloserine; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Proton Magnetic Resonance Spectroscopy | 2016 |
Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Female; Glutamine; Ketamine; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neurons; Neurotransmitter Agents; Prefrontal Cortex; Receptors, AMPA; Receptors, GABA; Signal Transduction; Swimming; Synapses; Synaptic Potentials; Synaptic Transmission; Video Recording | 2019 |
Therapeutic potentiality of a new flavonoid against ketamine induced glutamatergic dysregulation in schizophrenia: In vivo and in silico approach.
Topics: Animals; Antipsychotic Agents; Brain; Celastrus; Flavonoids; Glutamate Dehydrogenase; Glutamate-Ammonia Ligase; Glutaminase; Glutamine; Ketamine; Male; Molecular Docking Simulation; Neuroprotective Agents; Rats, Wistar; Schizophrenia | 2021 |
Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism.
Topics: Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Ketamine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy | 2022 |